Skip to main content

Microarrayer Shop Aushon BioSystems Closes $7.8M in Series A Financing

NEW YORK (GenomeWeb News) — Microarrayer developer Aushon BioSystems has raised $7.8 million in a Series A financing round, the company said today.
 
Financing company North Bridge Venture Partners led the round, which ended on Oct. 12, Aushon said.
 
The early stage company, based in Burlington, Mass., makes microarrayers for protein, antibody, and cell research. Its clients include the National Institutes of Health, M.D. Anderson Cancer Center, and George Mason University.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.